134 related items for PubMed ID: 37335578
1. Single- versus Divided-Dose Prednisolone for the First Episode of Nephrotic Syndrome in Children: An Open-Label RCT.
Khan T, Akhtar S, Mukherjee D, Basu S, Tse Y, Sinha R.
Clin J Am Soc Nephrol; 2023 Oct 01; 18(10):1294-1299. PubMed ID: 37335578
[Abstract] [Full Text] [Related]
2. Adrenocortical suppression increases the risk of relapse in nephrotic syndrome.
Abeyagunawardena AS, Hindmarsh P, Trompeter RS.
Arch Dis Child; 2007 Jul 01; 92(7):585-8. PubMed ID: 17284479
[Abstract] [Full Text] [Related]
3. Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT.
Webb NJ, Woolley RL, Lambe T, Frew E, Brettell EA, Barsoum EN, Trompeter RS, Cummins C, Wheatley K, Ives NJ.
Health Technol Assess; 2019 May 01; 23(26):1-108. PubMed ID: 31156083
[Abstract] [Full Text] [Related]
4. Randomized, Controlled Trial of Tacrolimus and Prednisolone Monotherapy for Adults with De Novo Minimal Change Disease: A Multicenter, Randomized, Controlled Trial.
Medjeral-Thomas NR, Lawrence C, Condon M, Sood B, Warwicker P, Brown H, Pattison J, Bhandari S, Barratt J, Turner N, Cook HT, Levy JB, Lightstone L, Pusey C, Galliford J, Cairns TD, Griffith M.
Clin J Am Soc Nephrol; 2020 Feb 07; 15(2):209-218. PubMed ID: 31953303
[Abstract] [Full Text] [Related]
5. Single- versus divided-dose prednisolone therapy for relapses of nephrotic syndrome.
Ekka BK, Bagga A, Srivastava RN.
Pediatr Nephrol; 1997 Oct 07; 11(5):597-9. PubMed ID: 9323286
[Abstract] [Full Text] [Related]
6. Daily low-dose prednisolone to prevent relapse of steroid-sensitive nephrotic syndrome in children with an upper respiratory tract infection: PREDNOS2 RCT.
Christian MT, Webb NJ, Woolley RL, Afentou N, Mehta S, Frew E, Brettell EA, Khan AR, Milford DV, Bockenhauer D, Saleem MA, Hall AS, Koziell A, Maxwell H, Hegde S, Finlay ER, Gilbert RD, Jones C, McKeever K, Cook W, Ives N.
Health Technol Assess; 2022 Jan 07; 26(3):1-94. PubMed ID: 35060851
[Abstract] [Full Text] [Related]
7. Short-Duration Prednisolone in Children with Nephrotic Syndrome Relapse: A Noninferiority Randomized Controlled Trial.
Kainth D, Hari P, Sinha A, Pandey S, Bagga A.
Clin J Am Soc Nephrol; 2021 Feb 08; 16(2):225-232. PubMed ID: 33478976
[Abstract] [Full Text] [Related]
8. Efficacy of body weight vs body surface area-based prednisolone regimen in nephrotic syndrome.
Basu B, Bhattacharyya S, Barua S, Naskar A, Roy B.
Clin Exp Nephrol; 2020 Jul 08; 24(7):622-629. PubMed ID: 32201918
[Abstract] [Full Text] [Related]
9. Single vs split dose of prednisolone in the treatment of relapses of childhood nephrotic syndrome.
Weerasooriya WALK, Abeyagunawardena AS, Thalgahagoda RS.
Eur J Pediatr; 2023 Apr 08; 182(4):1741-1747. PubMed ID: 36757496
[Abstract] [Full Text] [Related]
10. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
Rensen N, Gemke RJ, van Dalen EC, Rotteveel J, Kaspers GJ.
Cochrane Database Syst Rev; 2017 Nov 06; 11(11):CD008727. PubMed ID: 29106702
[Abstract] [Full Text] [Related]
11. Steroid treatment for the first episode of childhood nephrotic syndrome: comparison of the 8 and 12 weeks regimen using an individual patient data meta-analysis.
Schijvens AM, Teeninga N, Dorresteijn EM, Teerenstra S, Webb NJ, Schreuder MF.
Eur J Pediatr; 2021 Sep 06; 180(9):2849-2859. PubMed ID: 33774744
[Abstract] [Full Text] [Related]
12. Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluation.
Webb NJA, Woolley RL, Lambe T, Frew E, Brettell EA, Barsoum EN, Trompeter RS, Cummins C, Deeks JJ, Wheatley K, Ives NJ, PREDNOS Collaborative Group.
BMJ; 2019 May 23; 365():l1800. PubMed ID: 31335316
[Abstract] [Full Text] [Related]
13. Hypothalamic-pituitary-adrenal axis recovery following prolonged prednisolone therapy in infants.
Mendoza-Cruz AC, Wargon O, Adams S, Tran H, Verge CF.
J Clin Endocrinol Metab; 2013 Dec 23; 98(12):E1936-40. PubMed ID: 24081733
[Abstract] [Full Text] [Related]
14. Efficacy of low-dose daily versus alternate-day prednisolone in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.
Yadav M, Sinha A, Khandelwal P, Hari P, Bagga A.
Pediatr Nephrol; 2019 May 23; 34(5):829-835. PubMed ID: 30194663
[Abstract] [Full Text] [Related]
15. Body weight-based prednisolone versus body surface area-based prednisolone regimen for induction of remission in children with nephrotic syndrome: a randomized, open-label, equivalence clinical trial.
Raman V, Krishnamurthy S, Harichandrakumar KT.
Pediatr Nephrol; 2016 Apr 23; 31(4):595-604. PubMed ID: 26759000
[Abstract] [Full Text] [Related]
16. Randomized clinical trial to compare efficacy and safety of repeated courses of rituximab to single-course rituximab followed by maintenance mycophenolate-mofetil in children with steroid dependent nephrotic syndrome.
Basu B, Preussler S, Sander A, Mahapatra TKS, Schaefer F.
BMC Nephrol; 2020 Nov 30; 21(1):520. PubMed ID: 33256621
[Abstract] [Full Text] [Related]
17. Interventions for minimal change disease in adults with nephrotic syndrome.
Azukaitis K, Palmer SC, Strippoli GF, Hodson EM.
Cochrane Database Syst Rev; 2022 Mar 01; 3(3):CD001537. PubMed ID: 35230699
[Abstract] [Full Text] [Related]
18. Low-dose versus conventional-dose prednisolone for nephrotic syndrome relapses: a randomized controlled non-inferiority trial.
Sheikh S, Mishra K, Kumar M.
Pediatr Nephrol; 2021 Oct 01; 36(10):3143-3150. PubMed ID: 33861375
[Abstract] [Full Text] [Related]
19. Study protocol: high-dose mizoribine with prednisolone therapy in short-term relapsing steroid-sensitive nephrotic syndrome to prevent frequent relapse (JSKDC05 trial).
Hama T, Nakanishi K, Ishikura K, Ito S, Nakamura H, Sako M, Saito-Oba M, Nozu K, Shima Y, Iijima K, Yoshikawa N, Japanese Study Group of Kidney Disease in Children (JSKDC).
BMC Nephrol; 2018 Sep 10; 19(1):223. PubMed ID: 30200895
[Abstract] [Full Text] [Related]
20. Evaluation of Daily Low-Dose Prednisolone During Upper Respiratory Tract Infection to Prevent Relapse in Children With Relapsing Steroid-Sensitive Nephrotic Syndrome: The PREDNOS 2 Randomized Clinical Trial.
Christian MT, Webb NJA, Mehta S, Woolley RL, Afentou N, Frew E, Brettell EA, Khan AR, Milford DV, Bockenhauer D, Saleem MA, Hall AS, Koziell A, Maxwell H, Hegde S, Prajapati H, Gilbert RD, Jones C, McKeever K, Cook W, Ives N.
JAMA Pediatr; 2022 Mar 01; 176(3):236-243. PubMed ID: 34928294
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
